Pacira BioSciences' Change in Cash fell 1395284.93% to -$152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$98.4 million, marking a year-over-year decrease of 16699.26%. This contributed to the annual value of $123.5 million for FY2024, which is 15117.68% up from last year.
Latest data reveals that Pacira BioSciences reported Change in Cash of -$152.9 million as of Q3 2025, which was down 1395284.93% from $16.9 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Change in Cash peaked at $451.5 million during Q4 2021, and registered a low of -$358.8 million during Q1 2022.
Moreover, its 5-year median value for Change in Cash was $12.3 million (2023), whereas its average is $2.5 million.
In the last 5 years, Pacira BioSciences' Change in Cash skyrocketed by 188566.85% in 2021 and then plummeted by 1395284.93% in 2025.
Pacira BioSciences' Change in Cash (Quarter) stood at $451.5 million in 2021, then tumbled by 101.17% to -$5.3 million in 2022, then skyrocketed by 1125.15% to $54.2 million in 2023, then tumbled by 43.13% to $30.8 million in 2024, then crashed by 596.27% to -$152.9 million in 2025.
Its Change in Cash stands at -$152.9 million for Q3 2025, versus $16.9 million for Q2 2025 and $6.8 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value